课题基金 / 基金详情

Acquisition of a High Resolution Orbitrap Mass Spectrometer for Analysis of Prote

Acquisition of a High Resolution Orbitrap Mass Spectrometer for Analysis of Prote
获取用于蛋白质分析的高分辨率 Orbitrap 质谱仪
批准号:
7497816
负责人:
W. Andy Tao
金额:
$96.87万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-21 至 2010-05-20

项目摘要

项目成果

W. Andy Tao的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The ability to identify protein post-translational modifications (PTMs) in complex biological samples is increasingly important in modern biomedical research. This proposal requests funds for the purchase of a ThermoFisher LTQ Orbitrap XL Mass Spectrometer equipped with nanoflow liquid chromatography and electron transfer dissociation (ETD) system. This will be the center piece for the proteomics platform for challenging PTM analyses. This instrument will provide ultra high resolution and high mass accuracy for confident protein identification and have unique features for multi-stage tandem mass spectrometry and novel dissociation methods for PTM analysis. There are no similar instruments to serve the NIH user group of 10 major and 7 minor users within a 60-mile radius of the Purdue University West Lafayette campus. The addition of the LTQ-Orbitrap mass spectrometer on the Purdue campus will have significant impact on the capacity of the biomedical research community to conduct leading edge basic and applied research. This effort will complement investigator-based research on instrument development and applications and provide a platform for timely transfer of state-of-art approaches in PTM mapping to a broader group of biologists. The home academic units, the Purdue Cancer Center and the Bindley Bioscience Center, will work cooperatively with the PIs to ensure the proper management and optimum conditions for high quality data production. The instrument will provide a vital component of the PTM analysis platform and serve as a major analysis tool for several members of the Purdue Cancer Center.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1002/anie.201911078
发表时间: 2020-02-03
期刊: Angewandte Chemie (International ed. in English)
影响因子: --
作者: [Zhang Y, Kao DS, Gu B, Bomjan R, Srivastava M, Lu H, Zhou D, Tao WA]
通讯作者: Tao WA
DOI: 10.1002/anie.201006459
发表时间: 2011-04-26
期刊: ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
影响因子: 16.6
作者: [Hu, Lianghai, Iliuk, Anton, Galan, Jacob, Hans, Michael, Tao, W. Andy]
通讯作者: Tao, W. Andy
Developing high throughput measurement of thiopurine in DNA by mass spectrometry
Developing EV surface proteins as biosignatures for Alzheimer's disease (AD)
Dissecting signaling pathways and seeking EV phosphoproteins as novel biomarkers for Alzheimer's Disease
  • 批准号:
    10399815
  • 项目类别:
  • 资助金额:
    $12.34万
  • 财政年份:
    2020
  • 负责人:
    W. Andy Tao
  • 依托单位:
Developing novel RPPA for the detection of metastatic prostate cancer
国内基金
海外基金
Handbook of the Mathematics of the Arts and Sciences的中文翻译
  • 批准号:
    12226504
  • 项目类别:
    数学天元基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2022
  • 负责人:
    黄朝凌
  • 依托单位:
ARTS在邻苯二甲酸(2-乙基己基)酯诱导的小鼠睾丸间质细胞凋亡中的作用及机理研究
  • 批准号:
    --
  • 项目类别:
    --
  • 资助金额:
    35万元
  • 批准年份:
    2020
  • 负责人:
    陈加祥
  • 依托单位:
ARTS在邻苯二甲酸(2-乙基己基)酯诱导的小鼠睾丸间质细胞凋亡中的作用及机理研究
  • 批准号:
    82060278
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    35.0万元
  • 批准年份:
    2020
  • 负责人:
    陈加祥
  • 依托单位:
促进肿瘤凋亡的融合蛋白CPP-TRAIL-ARTS C27的制备及机制研究
  • 批准号:
    81372444
  • 项目类别:
    面上项目
  • 资助金额:
    70.0万元
  • 批准年份:
    2013
  • 负责人:
    易成
  • 依托单位: